Skip to main content
. 2022 Aug 15;15:947513. doi: 10.3389/fnmol.2022.947513

Table 1.

General characteristics of the participants in the study.

Variables Total population
(n = 219)
ASD
(n = 135)
Controls
(n = 84)
p-value
Age, years 3.25 (3.00,3.83) 3.25 (2.75,4.25) 3.33 (3.50,3.00) 0.647
 ≤3 82 (37.4) 55 (40.7) 27 (32.1) 0.251
 >3 137 (62.6) 80 (59.3) 57 (67.9)
Men, n (%) 181 (82.60) 117 (86.70) 64 (76.20) 0.066
BMI, kg/m 2 16.09 ± 1.90 16.39 ± 1.90 15.59 ± 1.81 <0.001
ZBMIA 0.38 ± 1.40 0.65 ± 1.33 −0.05 ± 1.40 0.001
Overweight 26 (11.87) 23 (9.6) 3 (3.6) 0.002
Developmental delay, n (%) 115 (52.51) 115 (85.2) 0
Picky eating, n (%) 97 (44.29) 77 (79.40) 20 (20.60) 0.001
Resistance to vegetables, n (%) 70 (31.96) 57 (81.4) 13 (18.6) <0.001
Resistance to meats,
n (%)
36 (16.44) 27 (75.0) 9 (25.0) 0.091
Resistance to fruits,
n (%)
14 (6.40) 11 (78.60) 3 (21.40) 0.258
History of taking vitamins, n (%) 86 (39.27) 71 (82.6) 15 (17.4) <0.001
Severity of ASD, n (%)
Mild to moderate 65 (29.68) 65 (48.1) 0
Severe 70 (31.96) 70 (51.9) 0
Hcy, μmol/L 6.68 (5.30, 7.95) 7.50 (6.70, 8.90) 5.15 (4.49, 6.03) 0.005
Folate, nmol/L 29.3 (19.6, 37.7) 27.6 (17.6, 34.8) 31.4 (23.5, 40.5) 0.003
VitB12, pmol/L 583 (415, 772) 530 (369, 708) 649 (478, 839) 0.005

BMI, body mass index; ZBMIA, z score for BMI-for-age; ASD, autism spectrum disorder; Hcy, homocysteine; VitB12, vitamin B12. Overweight is defined as a ZBMIA > 2. Data are presented as number (percentage) for categorical data, mean ± standard deviation for parametrically distributed data, or median (interquartile range) for non-parametrically distributed data. Student's t-test or the Wilcoxon rank sum test was used for comparison of the continuous variables according to the data distribution, and chi-square tests were used for the categorical variables.